TY  - JOUR
AU  - Perdomo, Carolina M
AU  - Nuñez-Cordoba, Jorge M
AU  - Ezponda, Ana
AU  - Mendoza, Francisco J
AU  - Ampuero, Javier
AU  - Bastarrika, Gorka
AU  - Frühbeck, Gema
AU  - Escalada, Javier
PY  - 2022
DO  - 10.3389/fmed.2022.1023583
SN  - 2296-858X
UR  - http://hdl.handle.net/10668/20614
T2  - Frontiers in medicine
AB  - To better understand the patient's heterogeneity in fatty liver disease (FLD), metabolic dysfunction-associated fatty liver disease (MAFLD) was proposed by international experts as a new nomenclature for nonalcoholic fatty liver disease (NAFLD). We...
LA  - en
PB  - Frontiers Research Foundation
KW  - coronary artery calcium
KW  - epicardial adipose tissue
KW  - metabolic dysfunction-associated fatty liver disease
KW  - nonalcoholic fatty liver disease
KW  - visceral adipose tissue
KW  - Non-alcoholic Fatty Liver Disease
KW  - Cross-Sectional Studies
KW  - Cardiovascular Diseases
KW  - Coronary Vessels
KW  - Epicardial Adipose Tissue
KW  - Obesity
KW  - Calcium, Dietary
KW  - Diabetes Mellitus, Type 2
KW  - Primary Prevention
KW  - Phenotype
TI  - Cardiometabolic characterization in metabolic dysfunction-associated fatty liver disease.
TY  - research article
VL  - 9
ER  -